Hopkinton, MA, United States of America

Donald Jude Brown

This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignees: Arteriocyte Inc., Université Pierre Et Marie Curie (Paris Vi). Active years: 2014-2026.

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Donald J Brown

Introduction

Donald J Brown is an accomplished inventor based in Hopkington, MA (US). He has made significant contributions to the field of biomedical engineering, particularly in the area of cell differentiation and tissue regeneration. His innovative work has the potential to impact the treatment of ischemic conditions.

Latest Patents

Donald J Brown holds a patent for "Erythrocytes differentiated in vitro from nanofiber expanded CD133+ cells." This invention provides methods and systems for expanding CD133+ cells, which are crucial for increasing blood flow to ischemic tissues, such as ischemic myocardium. The patent also outlines methods for directing the differentiation of these expanded cells and treating subjects with the differentiated cells.

Career Highlights

Throughout his career, Donald has worked with notable organizations, including Arteriocyte Inc. and Université Pierre Et Marie Curie (Paris VI). His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Ramasamy Sakthivel and Hai-Quan Mao. Their collaborative efforts have further advanced the research and applications of cell differentiation techniques.

Conclusion

Donald J Brown's innovative work in cell differentiation and tissue regeneration showcases his commitment to advancing medical science. His contributions have the potential to improve treatment options for patients with ischemic conditions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…